82 FR 35041 - Agency Information Collection Activities; Information Collection Revision Request-Medical Qualification Requirements, OMB Control Number 2126-0006

DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration

Federal Register Volume 82, Issue 143 (July 27, 2017)

Page Range		35041-35043
FR Document		2017-15835

In accordance with the Paperwork Reduction Act of 1995, FMCSA announces that it is considering submitting the Information Collection Request (ICR) described below to the Office of Management and Budget (OMB) for its review and approval and invites public comment on a revision to the Information Collection (IC) titled Medical Qualification Requirements, covered by OMB Control Number 2126-0006, which is currently due to expire on August 31, 2018. This revision is due to the Agency's anticipation of a final rule to revise its regulations to eliminate the blanket prohibition against insulin- dependent diabetic individuals' operation of commercial motor vehicles (CMV) in interstate commerce. The final rule is based on the Agency's 2015 Notice of Proposed Rulemaking (NPRM) and subsequent announcement of the availability of recommendations provided by FMCSA's Medical Review Board (MRB) after an analysis of the comments received in response to the NPRM. Based on the MRB's analysis of the comments and their recommendations, FMCSA is considering replacing the previously proposed written notification from the treating clinician (TC) with a form titled Insulin-Treated Diabetes Mellitus Assessment Form to be completed by the TC and provided to the certified medical examiner (certified ME). This form could be required for CMV drivers treated with insulin for diabetes who wish to drive in interstate commerce. FMCSA invites public comment on the proposed IC revision and the form that it is being considered.

Federal Register, Volume 82 Issue 143 (Thursday, July 27, 2017)

[Federal Register Volume 82, Number 143 (Thursday, July 27, 2017)]
[Notices]
[Pages 35041-35043]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-15835]



[[Page 35041]]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2005-23151]


Agency Information Collection Activities; Information Collection 
Revision Request--Medical Qualification Requirements, OMB Control 
Number 2126-0006

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.

ACTION: Notice and request for comments.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Paperwork Reduction Act of 1995, FMCSA 
announces that it is considering submitting the Information Collection 
Request (ICR) described below to the Office of Management and Budget 
(OMB) for its review and approval and invites public comment on a 
revision to the Information Collection (IC) titled Medical 
Qualification Requirements, covered by OMB Control Number 2126-0006, 
which is currently due to expire on August 31, 2018. This revision is 
due to the Agency's anticipation of a final rule to revise its 
regulations to eliminate the blanket prohibition against insulin-
dependent diabetic individuals' operation of commercial motor vehicles 
(CMV) in interstate commerce. The final rule is based on the Agency's 
2015 Notice of Proposed Rulemaking (NPRM) and subsequent announcement 
of the availability of recommendations provided by FMCSA's Medical 
Review Board (MRB) after an analysis of the comments received in 
response to the NPRM. Based on the MRB's analysis of the comments and 
their recommendations, FMCSA is considering replacing the previously 
proposed written notification from the treating clinician (TC) with a 
form titled Insulin-Treated Diabetes Mellitus Assessment Form to be 
completed by the TC and provided to the certified medical examiner 
(certified ME). This form could be required for CMV drivers treated 
with insulin for diabetes who wish to drive in interstate commerce. 
FMCSA invites public comment on the proposed IC revision and the form 
that it is being considered.

DATES: We must receive your comments on or before September 25, 2017.

ADDRESSES: You may submit comments identified by Federal Docket 
Management System (FDMS) Docket Number FMCSA-2005-23151 using any of 
the following methods:
     Federal eRulemaking Portal: http://www.regulations.gov. 
Follow the online instructions for submitting comments.
     Fax: 1-202-493-2251.
     Mail: Docket Services; U.S. Department of Transportation, 
1200 New Jersey Avenue SE., West Building, Ground Floor, Room W12-140, 
Washington, DC 20590-0001.
     Hand Delivery or Courier: U.S. Department of 
Transportation, 1200 New Jersey Avenue SE., West Building, Ground 
Floor, Room W12-140, Washington, DC, between 9 a.m. and 5 p.m. e.t., 
Monday through Friday, except Federal holidays.
    Instructions: All submissions must include the Agency name and 
docket number. For detailed instructions on submitting comments and 
additional information on the exemption process, see the Public 
Participation heading below. Note that all comments received will be 
posted without change to http://www.regulations.gov, including any 
personal information provided. Please see the Privacy Act heading 
below.
    Docket: For access to the docket to read background documents or 
comments received, go to http://www.regulations.gov, and follow the 
online instructions for accessing the dockets, or go to the street 
address listed above.
    Privacy Act: Anyone is able to search the electronic form of all 
comments received into any of our dockets by the name of the individual 
submitting the comment (or signing the comment, if submitted on behalf 
of an association, business, labor union, etc.). You may review DOT's 
complete Privacy Act Statement for the Federal Docket Management System 
published in the Federal Register on January 17, 2008 (73 FR 3316), or 
you may visit http://edocket.access.thefederalregister.org/2008/pdfE8-794.pdf.
    Public Participation: The Federal eRulemaking Portal is available 
24 hours each day, 365 days each year. You can obtain electronic 
submission and retrieval help and guidelines under the ``help'' section 
of the Federal eRulemaking Portal Web site. If you want us to notify 
you that we received your comments, please include a self-addressed, 
stamped envelope or postcard, or print the acknowledgement page that 
appears after submitting comments online. Comments received after the 
comment closing date will be included in the docket and will be 
considered to the extent practicable.

FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief, 
Medical Programs Division, U.S. Department of Transportation, Federal 
Motor Carrier Safety Administration, West Building 6th Floor, 1200 New 
Jersey Avenue SE., Washington, DC 20590. Telephone: 202-366-4001; email 
[email protected].

SUPPLEMENTARY INFORMATION:

Background

    The primary mission of FMCSA is to reduce crashes, injuries, and 
fatalities involving large trucks and buses. The Secretary of 
Transportation has delegated to FMCSA its responsibility under 49 
U.S.C. 31136, 31149 and 31502 to prescribe regulations that ensure that 
CMVs are operated safely. As part of this mission, the Agency's Medical 
Programs Division works to ensure that CMV drivers engaged in 
interstate commerce are physically qualified and able to safely perform 
their work.
    Information used to determine and certify driver medical fitness 
must be collected for our highways to be safe. FMCSA is the Federal 
government agency authorized to require the collection of this 
information and the authorizing regulations are located at 49 CFR 390-
399. FMCSA is required by statute to establish standards for the 
physical qualifications of drivers who operate CMVs in interstate 
commerce for non-excepted industries (49 U.S.C. 31136(a)(3), 
31149(c)(1)(A)(i), and 31502(b)). The regulations relevant to this 
collection are outlined in the Federal Motor Carrier Safety Regulations 
(FMCSRs) at 49 CFR 390-399. The FMCSRs at 49 CFR 391.41 set forth the 
physical qualification standards that interstate CMV drivers who are 
subject to part 391 must meet, with the exception of drivers operating 
vehicles transporting migrant workers (who must meet the physical 
qualification standards set forth in 49 CFR 398.3). The FMCSRs covering 
driver physical qualification records are found at 49 CFR 391.43, which 
specify that a medical examination be performed on CMV drivers subject 
to part 391 who operate in interstate commerce. The results of the 
examination must be recorded in accordance with the requirements set 
forth in that section.
    Section 391.41(b)(3) states that a person is physically qualified 
to drive a CMV if that person has no established medical history or 
clinical diagnosis of diabetes mellitus currently requiring insulin for 
control. As such, drivers with insulin-treated diabetes mellitus (ITDM) 
are currently prohibited from driving CMVs in interstate commerce 
unless they obtain an exemption from FMCSA.
    On May 4, 2015 (80 FR 25260), FMCSA published a NPRM proposing to 
revise Sec.  391.41(b)(3) to permit drivers with stable, well 
controlled ITDM to be

[[Page 35042]]

qualified to operate CMVs in interstate commerce who meet the proposed 
new requirements of Sec. Sec.  391.45 and 391.46. The proposal would 
enable drivers with ITDM to obtain a Medical Examiner's Certificate 
(MEC), Form MCSA-5876, from a certified ME at least annually to operate 
a CMV in interstate commerce if the TC provides documentation to the 
certified ME that the condition is stable and well controlled.
    To assist in the development of the final rule, FMCSA requested 
that the MRB, under MRB Task 15-1, review and analyze all comments from 
medical professionals, labor and industry, and trade associations, and 
identify factors the Agency should consider when making decisions about 
the next steps in the diabetes rulemaking. In July 2015, the MRB 
deliberated on these public comments for purposes of offering 
recommendations to the Agency on this topic.
    In September of 2015, the MRB provided several detailed 
recommendations in a final report of Task 15-1 to the Agency. In the 
report, the MRB recommended that FMCSA develop a questionnaire for the 
TC to send to the certified ME. See Recommendation II E, ``FMCSA 
Drivers With Insulin Treated Diabetes Mellitus Assessment Form.'' In 
September 2016, the Agency published a Federal Register notice 
announcing the availability of and requesting comments on the MRB's 
Task 15-1 recommendations. The MRB's final report for Task 15-1 and the 
Federal Register notice are available in the docket for this rulemaking 
(in addition to being available on the Agency's public Web site).
    The Agency evaluated the MRB's recommendations, as well as public 
comments, and is considering the use of an assessment form titled 
Insulin-Treated Diabetes Mellitus Assessment Form. The Agency may 
modify the form and the information that would be collected in response 
to any comments received in response to this notice. The addition of 
this requirement will add 33,616 annual burden hours and $2,823,744 
annual salary costs. However, eliminating the Diabetes Exemption 
Program as proposed in the NPRM will result in 2,219 less annual burden 
hours and $68,645 less annual salary costs. Therefore, the final rule 
would provide a net increase of 31,397 in annual burden hours and 
$2,755,099 in salary costs from the proposed updated annual burden 
hours and costs. The form that is being considered would include the 
following information collected by the TC:

CMV Driver Information

1. Name
2. DOB
3. Information about the driver's use of insulin:
    a. Whether the driver is newly diagnosed or an established insulin 
user
    b. Date insulin use began
    c. Whether or not the driver has been on a stable insulin regimen 
for three months prior
4. Information about the driver's use of blood glucose self-monitoring 
records
    a. Whether or not the driver provided documentation of ongoing 
self-monitoring of blood glucose measured with an electronic glucometer 
for at least the preceding three months
    b. Number of times per day the driver is testing their blood 
glucose
    c. Whether or not the driver is compliant with glucose monitoring 
based on his/her specific treatment plan
5. Information about insulin management and diabetes control
    a. Whether or not the driver has experienced any severe 
hypoglycemic episodes within the preceding three months
    b. Whether or not the driver has experienced any severe 
hypoglycemic episodes in the absence of warning symptoms in the 
preceding three months
    c. Whether or not the driver has had his/her HbA1C measured 
intermittently over the last 12 months with the most recent measure 
within the preceding three months accompanied by a copy of the most 
recent laboratory results.
6. Information about diabetes complications
    a. Whether or not the driver has any signs of diabetes 
complications or target organ damage that impairs the driver's ability 
to safely operate a CMV
7. Information about progressive eye diseases
    a. Date of last comprehensive dilated eye examination
    b. Whether or not the driver has been diagnosed with Stage 3 or 4 
diabetic retinopathy
    c. Whether or not the driver has been diagnosed with any other 
progressive eye disease(s)
8. Any comments provided by the TC

TC Information

1. Certification that they are the treating clinician for the driver 
and that the driver maintains a stable insulin regimen and stable 
control of his/her insulin-treated diabetes mellitus.
2. Date
3. Name
4. Signature
5. Telephone Number
6. Email address
7. Street Address
8. City, State, and Zip Code

    The public interest in, and the right to have, safe highways 
requires the assurance that drivers of CMVs can safely perform the 
increased physical and mental demands of their duties. FMCSA's medical 
standards provide this assurance by requiring drivers to be examined 
and medically certified as physically and mentally qualified to drive a 
CMV.
    Therefore, the information collected on this assessment form could 
assist the certified ME in determining if the driver with ITDM that is 
being examined is medically qualified under 49 CFR 391.41 to operate a 
CMV, and to ensure that there are no medical conditions that could 
adversely affect his or her ability to drive safely or cause 
incapacitation constituting a risk to the public.
    The use of this form could allow the certified ME to have 
communication with TCs so that the certified ME fully understands 
whether the driver with ITDM that is being examined has stable, well-
controlled diabetes. This information will assist the ME in determining 
whether insulin treatment or any medical complications of diabetes will 
impact a driver's ability to safely operate a CMV. Therefore, FMCSA 
expects that 100 percent of drivers who are treated with insulin and 
intend to operate a CMV in interstate commerce will have the form 
completed by their TC.
    TCs would be able to fax or scan and email the form to the 
certified ME. Consistent with OMB's commitment to minimizing 
respondents' recordkeeping and paperwork burdens, and the increased use 
of secure electronic modes of communication, the Agency anticipates 
that approximately 25 percent of the Insulin-Treated Diabetes Mellitus 
Assessment Forms would be transmitted electronically.
    The information collected from the Insulin-Treated Diabetes 
Mellitus Assessment Form provided to the certified ME will become part 
of the CMV driver's record maintained for at least three years by the 
certified ME. Therefore, the information will not be available to the 
public. The FMCSRs covering driver physical qualification records are 
found at 49 CFR 391.43, which specify that a medical

[[Page 35043]]

examination be performed on CMV drivers subject to part 391, subpart E 
who operate in interstate commerce. The results of the examination 
shall be recorded in accordance with the requirements set forth in that 
section.
    Title: Medical Qualification Requirements.
    OMB Control Number: 2126-0006.
    Type of Request: Revised collection.
    Respondents: Treating Clinicians (i.e., healthcare professional who 
manages and prescribes insulin for treatment of a driver's diabetes 
mellitus as authorized by the healthcare professional's applicable 
State licensing board).
    Estimated Number of Respondents: 252,117 treating clinicians.
    Estimated Time per Response: 8 minutes.
    Expiration Date: 8/31/2018.
    Frequency of Response: Required.
    Estimated Total Annual Burden: 33,616 hours.
    Public Comments Invited: You are asked to comment on any aspect of 
this information collection, including: (1) Whether the proposed 
collection is necessary for the performance of FMCSA's functions; (2) 
the accuracy of the estimated burden; (3) ways for FMCSA to enhance the 
quality, usefulness, and clarity of the collected information; and (4) 
ways that the burden could be minimized without reducing the quality of 
the collected information. The agency will summarize or include your 
comments in the request for OMB's clearance of this information 
collection.

    Issued under the authority of 49 CFR 1.87 on: July 20, 2017.
G. Kelly Regal,
Associate Administrator for Office of Research and Information 
Technology and Chief Information Officer.
[FR Doc. 2017-15835 Filed 7-26-17; 8:45 am]
 BILLING CODE 4910-EX-P

35042 Federal Register / Vol. 82, No. 143 / Thursday, July 27, 2017 / Notices

qualified to operate CMVs in interstate CMV Driver Information regimen and stable control of his/
commerce who meet the proposed new 1. Name her insulin-treated diabetes
requirements of §§ 391.45 and 391.46. 2. DOB mellitus.
The proposal would enable drivers with 3. Information about the driver’s use of 2. Date
ITDM to obtain a Medical Examiner’s insulin: 3. Name
Certificate (MEC), Form MCSA–5876, a. Whether the driver is newly 4. Signature
from a certified ME at least annually to diagnosed or an established insulin 5. Telephone Number
operate a CMV in interstate commerce if user 6. Email address
the TC provides documentation to the b. Date insulin use began 7. Street Address
certified ME that the condition is stable c. Whether or not the driver has been 8. City, State, and Zip Code
and well controlled. on a stable insulin regimen for three The public interest in, and the right
To assist in the development of the months prior to have, safe highways requires the
final rule, FMCSA requested that the 4. Information about the driver’s use of assurance that drivers of CMVs can
MRB, under MRB Task 15–1, review blood glucose self-monitoring safely perform the increased physical
and analyze all comments from medical records and mental demands of their duties.
professionals, labor and industry, and a. Whether or not the driver provided FMCSA’s medical standards provide
trade associations, and identify factors documentation of ongoing self- this assurance by requiring drivers to be
the Agency should consider when monitoring of blood glucose examined and medically certified as
making decisions about the next steps in measured with an electronic physically and mentally qualified to
the diabetes rulemaking. In July 2015, glucometer for at least the drive a CMV.
the MRB deliberated on these public preceding three months Therefore, the information collected
comments for purposes of offering b. Number of times per day the driver on this assessment form could assist the
recommendations to the Agency on this is testing their blood glucose certified ME in determining if the driver
topic. c. Whether or not the driver is with ITDM that is being examined is
In September of 2015, the MRB compliant with glucose monitoring medically qualified under 49 CFR
provided several detailed based on his/her specific treatment 391.41 to operate a CMV, and to ensure
recommendations in a final report of plan that there are no medical conditions that
Task 15–1 to the Agency. In the report, 5. Information about insulin could adversely affect his or her ability
the MRB recommended that FMCSA management and diabetes control to drive safely or cause incapacitation
develop a questionnaire for the TC to a. Whether or not the driver has constituting a risk to the public.
send to the certified ME. See experienced any severe The use of this form could allow the
Recommendation II E, ‘‘FMCSA Drivers hypoglycemic episodes within the certified ME to have communication
With Insulin Treated Diabetes Mellitus preceding three months with TCs so that the certified ME fully
Assessment Form.’’ In September 2016, b. Whether or not the driver has understands whether the driver with
the Agency published a Federal experienced any severe ITDM that is being examined has stable,
Register notice announcing the hypoglycemic episodes in the well-controlled diabetes. This
availability of and requesting comments absence of warning symptoms in information will assist the ME in
on the MRB’s Task 15–1 the preceding three months determining whether insulin treatment
recommendations. The MRB’s final c. Whether or not the driver has had or any medical complications of
report for Task 15–1 and the Federal his/her HbA1C measured diabetes will impact a driver’s ability to
Register notice are available in the intermittently over the last 12 safely operate a CMV. Therefore,
docket for this rulemaking (in addition months with the most recent FMCSA expects that 100 percent of
to being available on the Agency’s measure within the preceding three drivers who are treated with insulin and
public Web site). months accompanied by a copy of intend to operate a CMV in interstate
The Agency evaluated the MRB’s the most recent laboratory results. commerce will have the form completed
recommendations, as well as public 6. Information about diabetes by their TC.
comments, and is considering the use of complications TCs would be able to fax or scan and
an assessment form titled Insulin- a. Whether or not the driver has any email the form to the certified ME.
Treated Diabetes Mellitus Assessment signs of diabetes complications or Consistent with OMB’s commitment to
Form. The Agency may modify the form target organ damage that impairs minimizing respondents’ recordkeeping
and the information that would be the driver’s ability to safely operate and paperwork burdens, and the
collected in response to any comments a CMV increased use of secure electronic
received in response to this notice. The 7. Information about progressive eye modes of communication, the Agency
addition of this requirement will add diseases anticipates that approximately 25
33,616 annual burden hours and a. Date of last comprehensive dilated percent of the Insulin-Treated Diabetes
$2,823,744 annual salary costs. eye examination Mellitus Assessment Forms would be
However, eliminating the Diabetes b. Whether or not the driver has been transmitted electronically.
Exemption Program as proposed in the diagnosed with Stage 3 or 4 diabetic The information collected from the
NPRM will result in 2,219 less annual retinopathy Insulin-Treated Diabetes Mellitus
burden hours and $68,645 less annual c. Whether or not the driver has been Assessment Form provided to the
salary costs. Therefore, the final rule diagnosed with any other certified ME will become part of the
mstockstill on DSK30JT082PROD with NOTICES

would provide a net increase of 31,397 progressive eye disease(s) CMV driver’s record maintained for at
in annual burden hours and $2,755,099 8. Any comments provided by the TC least three years by the certified ME.
in salary costs from the proposed Therefore, the information will not be
updated annual burden hours and costs. TC Information available to the public. The FMCSRs
The form that is being considered would 1. Certification that they are the treating covering driver physical qualification
include the following information clinician for the driver and that the records are found at 49 CFR 391.43,
collected by the TC: driver maintains a stable insulin which specify that a medical

VerDate Sep<11>2014 19:17 Jul 26, 2017 Jkt 241001 PO 00000 Frm 00120 Fmt 4703 Sfmt 4703 E:\FR\FM\27JYN1.SGM 27JYN1

Federal Register / Vol. 82, No. 143 / Thursday, July 27, 2017 / Notices 35043

examination be performed on CMV Regulations (FMCSRs) to operate a FOR FURTHER INFORMATION CONTACT: Ms.
drivers subject to part 391, subpart E commercial motor vehicle (CMV) in Christine A. Hydock, Chief, Medical
who operate in interstate commerce. interstate commerce. If granted, the Programs Division, (202) 366–4001,
The results of the examination shall be exemptions will enable these fmcsamedical@dot.gov, FMCSA,
recorded in accordance with the individuals to operate CMVs in Department of Transportation, 1200
requirements set forth in that section. interstate commerce without meeting New Jersey Avenue SE., Room W64–
Title: Medical Qualification the vision requirement in one eye. 224, Washington, DC 20590–0001.
Requirements. DATES: Comments must be received on Office hours are 8:30 a.m. to 5 p.m., e.t.,
OMB Control Number: 2126–0006. or before August 28, 2017. Monday through Friday, except Federal
Type of Request: Revised collection. holidays. If you have questions
Respondents: Treating Clinicians (i.e., ADDRESSES: You may submit comments
regarding viewing or submitting
healthcare professional who manages bearing the Federal Docket Management material to the docket, contact Docket
and prescribes insulin for treatment of System (FDMS) Docket No. FMCSA– Services, telephone (202) 366–9826.
a driver’s diabetes mellitus as 2017–0019 using any of the following
SUPPLEMENTARY INFORMATION:
authorized by the healthcare methods:
professional’s applicable State licensing • Federal eRulemaking Portal: Go to I. Background
board). http://www.regulations.gov. Follow the Under 49 U.S.C. 31136(e) and 31315,
Estimated Number of Respondents: online instructions for submitting FMCSA may grant an exemption from
252,117 treating clinicians. comments. the Federal Motor Carrier Safety
Estimated Time per Response: 8 • Mail: Docket Management Facility; Regulations for a two-year period if it
minutes. U.S. Department of Transportation, 1200 finds ‘‘such exemption would likely
Expiration Date: 8/31/2018. New Jersey Avenue SE., West Building achieve a level of safety that is
Frequency of Response: Required. Ground Floor, Room W12–140, equivalent to or greater than the level
Estimated Total Annual Burden: Washington, DC 20590–0001. that would be achieved absent such
33,616 hours. • Hand Delivery: West Building exemption.’’ FMCSA can renew
Public Comments Invited: You are Ground Floor, Room W12–140, 1200 exemptions at the end of each two-year
asked to comment on any aspect of this New Jersey Avenue SE., Washington, period.
information collection, including: (1) DC, between 9 a.m. and 5 p.m., E.T., The 12 individuals listed in this
Whether the proposed collection is Monday through Friday, except Federal notice have each requested such an
necessary for the performance of Holidays. exemption from the vision requirement
FMCSA’s functions; (2) the accuracy of • Fax: 1–202–493–2251. in 49 CFR 391.41(b)(10). Accordingly,
the estimated burden; (3) ways for the Agency will evaluate the
Instructions: Each submission must
FMCSA to enhance the quality, qualifications of each applicant to
include the Agency name and the
usefulness, and clarity of the collected determine whether granting an
docket numbers for this notice. Note
information; and (4) ways that the exemption will achieve the required
that all comments received will be
burden could be minimized without level of safety mandated by statute.
posted without change to http://
reducing the quality of the collected The physical qualification standard
www.regulations.gov, including any
information. The agency will summarize for drivers regarding vision found in 49
personal information provided. Please
or include your comments in the request CFR 391.41(b)(10) states that a person is
see the Privacy Act heading below for
for OMB’s clearance of this information physically qualified to drive a CMV if
further information.
collection. that person:
Docket: For access to the docket to
Issued under the authority of 49 CFR 1.87 read background documents or Has distant visual acuity of at least 20/40
on: July 20, 2017. comments, go to http:// (Snellen) in each eye without corrective
G. Kelly Regal, www.regulations.gov at any time or lenses or visual acuity separately corrected to
Associate Administrator for Office of 20/40 (Snellen) or better with corrective
Room W12–140 on the ground level of lenses, distant binocular acuity of at least 20/
Research and Information Technology and the West Building, 1200 New Jersey
Chief Information Officer. 40 (Snellen) in both eyes with or without
Avenue SE., Washington, DC, between 9 corrective lenses, field of vision of at least
[FR Doc. 2017–15835 Filed 7–26–17; 8:45 am] a.m. and 5 p.m., E.T., Monday through 70° in the horizontal Meridian in each eye,
BILLING CODE 4910–EX–P Friday, except Federal holidays. The and the ability to recognize the colors of
FDMS is available 24 hours each day, traffic signals and devices showing standard
365 days each year. If you want red, green, and amber.
DEPARTMENT OF TRANSPORTATION acknowledgment that we received your In July 1992, the Agency first
Federal Motor Carrier Safety comments, please include a self- published the criteria for the Vision
Administration addressed, stamped envelope or Waiver Program, which listed the
postcard or print the acknowledgement conditions and reporting standards that
[Docket No. FMCSA–2017–0019] page that appears after submitting CMV drivers approved for participation
comments on-line. would need to meet (Qualification of
Qualification of Drivers; Exemption Privacy Act: In accordance with 5 Drivers; Vision Waivers, 57 FR 31458,
Applications; Vision U.S.C. 553(c), DOT solicits comments July 16, 1992). The current Vision
AGENCY: Federal Motor Carrier Safety from the public to better inform its Exemption Program was established in
Administration (FMCSA), DOT. rulemaking process. DOT posts these 1998, following the enactment of
mstockstill on DSK30JT082PROD with NOTICES

ACTION: Notice of applications for comments, without edit, including any amendments to the statutes governing
exemptions; request for comments. personal information the commenter exemptions made by § 4007 of the
provides, to http://www.regulations.gov, Transportation Equity Act for the 21st
SUMMARY: FMCSA announces receipt of as described in the system of records Century (TEA–21), Public Law 105–178,
applications from 12 individuals for notice (DOT/ALL–14 FDMS), which can 112 Stat. 107, 401 (June 9, 1998). Vision
exemption from the vision requirement be reviewed at http://www.dot.gov/ exemptions are considered under the
in the Federal Motor Carrier Safety privacy. procedures established in 49 CFR part

VerDate Sep<11>2014 19:17 Jul 26, 2017 Jkt 241001 PO 00000 Frm 00121 Fmt 4703 Sfmt 4703 E:\FR\FM\27JYN1.SGM 27JYN1

Document Created: 2017-07-27 02:06:54
Document Modified: 2017-07-27 02:06:54

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice and request for comments.
Dates		We must receive your comments on or before September 25, 2017.
Contact		Ms. Christine A. Hydock, Chief, Medical Programs Division, U.S. Department of Transportation, Federal Motor Carrier Safety Administration, West Building 6th Floor, 1200 New Jersey Avenue SE., Washington, DC 20590. Telephone: 202-366-4001; email [email protected]
FR Citation		82 FR 35041

82 FR 35041 - Agency Information Collection Activities; Information Collection Revision Request-Medical Qualification Requirements, OMB Control Number 2126-0006

DEPARTMENT OF TRANSPORTATIONFederal Motor Carrier Safety Administration

Federal Register Volume 82, Issue 143 (July 27, 2017)

DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration